• Exchange: New York
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

ACT:US

235.6200 USD 6.1900 2.56%

As of 20:04:01 ET on 09/22/2014.

Snapshot for Actavis plc (ACT)

Open: 239.8400 Day's Range: 234.4000 - 240.2600 Volume: 2,595,307
Previous Close: 241.8100 52wk Range: 136.3300 - 245.5000 1-Yr Rtn: +73.89%

Stock Chart for ACT

No chart data available.
  • ACT:US 235.6200
  • 1D
  • 1M
  • 1Y
241.8100
Interactive ACT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ACT

Current P/E Ratio (ttm) 57.1841
Estimated P/E(12/2014) 17.7398
Relative P/E vs. SPX 3.1672
Earnings Per Share (USD) (ttm) 4.1204
Est. EPS (USD) (12/2014) 13.2820
Est. PEG Ratio 1.1316
Market Cap (M USD) 62,265.11
Shares Outstanding (M) 264.26
30 Day Average Volume 1,793,602
Price/Book (mrq) 4.2403
Price/Sale (ttm) 3.8127
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/29/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ACT

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ACT

Actavis plc manufactures specialty pharmaceuticals. The Company develops, manufactures and distributes generic, brand and over-the-counter products. Actavis offers its pharmaceutical drugs around the world.

Paul M BisaroChairmanBrenton L Saunders "Brent"President/CEO
R Todd JoyceChief Financial OfficerRobert A Stewart "Bob"Chief Operating Officer
More Company Profile & Key Executives for ACT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil